Company / Working Capital per Share
Amneal Pharmaceuticals, Inc. Working Capital per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.85
FY2025
5-year range
$3.03 / $6.38
FY2021-FY2025
Trend
+92.6%
vs FY2024
Sector context
#95 of 210
Health Care
What the data says
At $5.85, Amneal Pharmaceuticals, Inc.'s working capital per share ranks #95 of 210 in the Health Care sector. Working Capital per Share returned to growth in FY2025 after 4 years of decline, reaching $5.85.
Based on SEC 10-K filings.
5.85 in FY2025 with a 5-year CAGR of -3.2%.
Improved from $3.50 to $5.85 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +9.7%
- 5-Year CAGR
- -3.2%
- 10-Year CAGR
- -
Sector benchmark
#95 of 210 in Health CareTop 45% of 210This company $5.85 Sector average $146.86
▼
-96.0% below sector average
Key checks
Key Insights
- In FY2025, working capital per share increased 92.6% year-over-year.
- Ranks #95 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2017.
- Lowest working capital per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.85 | +92.6% |
| FY2024 | $3.03 | -13.3% |
| FY2023 | $3.50 | -20.9% |
| FY2022 | $4.43 | -30.6% |
| FY2021 | $6.38 | -7.2% |
| FY2020 | $6.87 | +32.6% |
| FY2019 | $5.19 | -10.0% |
| FY2018 | $5.76 | -100.0% |
| FY2017 | $475050.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026